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ABSTRACT
Age-related Macular Degeneration (AMD) represents one of the most sight-
threatening diseases in developed countries that substantially impacts the patients’ 
lifestyle by compromising everyday activities, such as reading and driving. In 
this context, understanding the prevalence, burden, and population-specific risk/
protective factors of AMD is essential for adequate health care planning and provision. 
Our work aimed to characterize exudative AMD in Italian population and to identify 
the susceptibility/protective factors (genetic variants, age, sex, smoking and 
dietary habits) which are specific for the onset of disease. Our study involved a 
cohort of 1976 subjects, including 976 patients affected with exudative AMD and 
1000 control subjects. In particular, the sample cohort has been subjected to a 
large genotyping analysis of 20 genetic variants which are known to be associated 
with AMD among European and Asiatic populations. This analysis revealed that 8 
genetic variants (CFH, ARMS2, IL-8, TIMP3, SLC16A8, RAD51B, VEGFA and COL8A1) 
were significantly associated with AMD susceptibility. Successively, we performed a 
multivariate analysis, considering both genetic and non-genetic data available for our 
sample cohort. The multivariate analysis showed that age, smoking, dietary habits 
and sex, together with the genetic variants, were significantly associated with AMD 
in our population. Altogether, these data represent a starting point for the set-up of 
adequate preventive and personalized strategies aimed to decrease the burden of 
disease and improve the patients’ quality of life.
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INTRODUCTION
AMD affects approximately 21 million people 
worldwide, and it is the main cause of low vision among 
people aged 55 years and older [1–2]. In Italy, over 1 
million individuals manifest with initial symptoms of 
the disease, and 63000 new AMD cases are estimated 
each year [3]. The hallmarks of the disease include the 
progressive degeneration of the central part of the retina 
(macula) and drusen formation, changes that ultimately 
disrupt the cytoarchitectonics of the central retina and 
cause atrophy or abnormal choroidal neovascularization 
(CNV). According to the clinical phenotype, AMD is 
classified as non-exudative or exudative [3–5]. In the 
early stage of disease, fundus examination reveals the 
presence of non-exudative lesions such as drusen, areas 
of Retinal Pigment Epithelium (RPE) depigmentation 
or pigment clumping. These drusen typically occur with 
significant pigment changes and accumulation of pigment 
in the posterior pole. Morphological characteristics of the 
drusen (size, coalescence, extension) and the occurrence 
of pigment changes appear to be correlated with the risk of 
disease evolution. The late stage of AMD is characterized 
by either the presence of central retinal atrophy, termed 
geographic atrophy (GA), or the presence of an exudative 
neovascular lesion, known as choroidal neovascularization 
(CNV) [5–6]. In the presence of CNV, the abnormal blood 
vessels typically sprout from the choriocapillaris and can 
penetrate Bruch’s membrane (BrM) into the space beneath 
the RPE (type 1 CNV) or the subretinal space (type 2 
CNV). In some cases, neovascularization appears to 
initiate from the retinal vessels, induces detachment of the 
pigment epithelium and finally creates anastomosis with 
choroidal vasculature (Retinal Angiomatous Proliferation-
RAP or type 3 CNV).
Concerning the onset and the evolution of the 
disease, a number of triggering factors have been 
described up to date. First, aging is responsible for the loss 
of approximately 30% of rod photoreceptors and has been 
directly correlated with disease prevalence [3–4, 7–8]. 
Second, smoking is known to significantly increase the 
risk for AMD as a result of the RPE damage caused by 
the release of oxidative compounds contained in cigarettes 
[1, 5, 9–10]. The damages caused by cigarettes smoke 
appeared to be strongly correlated with the exudative form 
of AMD. Third, dietary habits, especially the consumption 
of food with antioxidant properties, are usually associated 
with slower disease progression towards more severe 
forms [1, 5, 11]. In fact, a number of studies have 
demonstrated that patients treated with antioxidant 
nutrients (carotenoids, vitamins, mineral elements and 
Omega-3 fatty acids) have 25% lower risk of progression 
towards the advanced stage of AMD and 19% lower 
risk of vision loss [12]. Moreover, subjects experiencing 
a healthy lifestyle (meant as regular consumption of 
antioxidant nutrients, no smoking and physical activity) 
had 3-fold lower risk of early AMD compared to people 
having unhealthy lifestyle [13]. 
Furthermore, familiarity is another susceptibility 
factor, showing an estimated value of 11% in the presence 
of affected first-degree relatives [3, 14].
The contribution of genomics to AMD has been so 
far described through several common and rare variants 
mapped on different genes. Of these, the following are 
noteworthy: CFH (rs1061170, T/C), ARMS2 (rs10490924, 
G/T), IL-8 (rs2227306, C/T), C2 (rs547154, C/A; 
rs9332739, G/C), CFB (rs4151667, T/A), C3 (rs2230199, 
C/G), C9 (rs62358361, G/T), CFI (rs4698775, G/T), 
TNFRSF10A (rs13278062, G/T), TIMP3 (rs5749482, 
C/G), VEGFA (rs943080, C/T), COL8A1 (rs13081855, 
G/T), SLC16A8 (rs8135665, G/T), RAD51B (rs8017304, 
A/G), ADAMTS9 (rs679573, C/T), LIPC (rs920915, C/G), 
APOE (rs4420638, A/G), COL10A1 (rs3812111, A/T), 
IER3-DDR1 (rs1864163, A/G), B3GALTL (rs9542236, 
C/T), TGFBR1 (rs334353, T/G), and CETP (rs1864163, 
G/A) [5, 15–17]. Currently, only CFH, ARMS2 and IL-8 
are known to be associated with AMD in the Italian 
population [3, 18–20]. Therefore, we performed a large 
genotyping analysis to determine the genetic variations 
associated with Italian patients affected by AMD. 
Successively, we performed a multivariate analysis, taking 
into account all genetic data and non-genetic factors (age, 
sex, smoking and dietary habits). The ultimate goal of the 
multivariate analysis was to determine the contribution of 
genetic and environmental factors to the onset of AMD 
in Italian patients. Moreover, bioinformatic analysis 
predicted some possible gene interactions at the basis of 
AMD pathogenesis. 
RESULTS
All of the 1976 samples were genotyped for the 
selected SNPs. Of the analyzed variants, only 8 SNPs 
yielded significant association values. As expected, we 
confirmed that rs1061170 (CFH), rs10490924 (ARMS2), 
rs2227306 (IL-8) had a strong association with AMD 
susceptibility in the Italian population. In addition, the 
biostatistical analysis revealed the association of 5 new 
SNPs in our population: rs5749482 (TIMP3), rs8017304 
(RAD51B), rs8135665 (SLC16A8), rs943080 (VEGFA), 
and rs13081855 (COL8A1). The other SNPs tested for 
statistical association did not yield significant values. The 
p and ORs for the 20 SNPs are reported in Table 1.
The multivariate logistic regression analysis was 
performed accounting for the 8 associated SNPs, age, 
sex, smoking and dietary (consumption of fruits and 
vegetables) habits collected from our Italian subjects. 
We performed 3 different levels of multivariate 
logistic regression analysis to estimate the contribution of 
genetic and non-genetic factors to AMD susceptibility. 
The first level of the multivariate analysis included 
only the frequency distribution of the 8 associated SNPs. 
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Interestingly, the logistic regression coefficient (R2) 
revealed that genetic factors account for 23% of the disease 
susceptibility. Moreover, the significant associations 
of CFH, ARMS2, IL-8, TIMP3, SLC16A8, VEGFA and 
COL8A1 were confirmed, while the association of 
RAD51B was not significant. This result suggested that 
RAD51B is a very low risk factor for AMD in the Italian 
population compared with stronger susceptibility genes.
The second level of the multivariate analysis was 
performed taking into account only the non-genetic 
factors, which were age, sex, smoking and dietary habits. 
The overall contribution of these variables to AMD 
susceptibility was estimated to be 10% (R2). In particular, 
advanced age and smoking status were strongly associated 
with a higher risk of AMD, while the regular consumption 
of fruits and vegetables showed to be protective from 
the disease. The association between sex and disease 
susceptibility was non-significant at this level of analysis. 
The p and ORs for each non-genetic variable are reported 
in Table 2.
The third level of the multivariate analysis included 
all genetic and non-genetic factors taken into consideration 
in our work. The logistic regression coefficient (R2) 
suggested that all of the tested variables were able to 
describe up to 29% of disease susceptibility. Overall, CFH 
and ARMS2 remained the most significant risk factors 
for AMD, while RAD51B was identified as the least 
relevant gene. Surprisingly, at this step of the analysis, 
sex appeared to be slightly associated with the disease. In 
particular, females appeared to be at lower risk for AMD 
with respect to males. The p and ORs for the genetic and 
non-genetic variables are reported in Table 3.
The bioinformatic analysis of the gene interactions 
through WEB-based GEne SeT AnaLysis Toolkit and 
DAVID Bioinformatic Database, provided different results 
depending on the selected enrichment tool (GO Analysis, 
Pathway Commons Analysis and Transcription Factor 
Target Analysis). With regard to biological processes, 
the GO Analysis revealed significant interactions for all 
the genes of interest (Figure 1). The Pathway Commons 
Analysis showed that VEGFA and IL-8 share different 
pathways (p ranging from 0.02 and 0.008), especially 
those involved in signaling, metabolism and regulation of 
immune and inflammatory events. In addition, RAD51B 
and SLC16A8 showed a significant interaction (p = 0.002) 
in the modulation of the haemostasis/coagulation pathway. 
Transcription Factor Target Analysis reported significant 
associations with some transcription factors (TF). Of 
these TFs, the most relevant target was NFAT, which was 
associated with VEGFA and COL8A1 (p = 0.004).
With regard to gene/phenotype interactions, 
analyses performed using SPSS software demonstrated 
an association between VEGFA and type 1 CNV, with 
p = 0.006 and OR = 1.97 (95% CI: 1.20–3.23); but no 
significant associations were observed for the type 2 
CNV subtype. However, the other genes did not appear 
Table 1: Association analysis results of the 20 selected SNPs
GENES SNPs LOCUS p OR (CI 95%) EFFECT
CFH rs1061170 (T/C) 1q31 1.05*10–34 C =  2.3 (2.0–2.6) risk
ARMS2 rs10490924 (G/T) 10q26 2.37*10–42 T =  2.6 (2.3–3.0) risk
IL8 rs2227306 (C/T) 4q13 1.53*10–05 T =  1.4 (1.2–1.5) risk
TIMP3 rs5749482 (C/G) 22q12.3 5.96*10–06 C = 1.6 (1.3–1.9) risk
LIPC rs920915 (C/G) 15q21 ns - -
APOE rs4420638 (A/G) 19p13.2 ns - -
VEGFA rs943080 (C/T) 6p21.1 1.13*10–04 T = 1.3 (1.1–1.4) risk
IER3-DDR1 rs1864163 (A/G) 6p21.3 ns - -
B3GALTL rs9542236 (C/T) 13q12.3 ns - -
TGFBR1 rs334353 (T/G) 9q22 ns - -
ADAMTS9 rs679573 (C/T) 3p14.1 ns -
COL10A1 rs3812111 (A/T) 6q21 ns - -
CETP rs1864163 (G/A) 16q21 ns - -
RAD51B rs8017304 (A/G) 14q23 0.007 G = 1.2 (1.0–1.4) risk
SLC16A8 rs8135665 (C/T) 22q13.1 1.89*10–08 T = 1.6 (1.4–1.9) risk
COL8A1 rs13081855 (G/T) 3q12.1 1.02*10–08 T = 2.0 (1.5–2.5) risk
C2 rs547154 (C/A) rs9332739 (G/C) 6p21.3 ns - -
CFB rs4151667 (T/A) 6p21.3 ns - -
C3 rs2230199 (C/G) 19p13.3 ns - -
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to affect a specific subtype of exudative AMD, rather they 
should be regarded as susceptibility genes regardless of 
the disease phenotype.
DISCUSSION
The contribution of genomics to the risk of 
developing AMD has been extensively explored 
among global populations, particularly in European 
and Asian groups. According to recent data and disease 
prevalence estimates, up to 34 loci are known to 
account for approximately 46–71% of the risk of AMD 
globally [1, 17]. 
This study was designed to assess the specific 
contribution of genetic and environmental factors to the 
onset of exudative AMD in Italian population. To this 
end, 1976 Italian subjects were genotyped for 20 variants, 
which have previously been associated with the disease in 
European and Asiatic populations. Given our results, only 
8 genetic variants (CFH, ARMS2, IL-8, TIMP3, SLC16A8, 
RAD51B, VEGFA and COL8A1) out of 20 reached the 
significance threshold fixed at p < 0.05. As expected, 
CFH and ARMS2 appeared to be the most associated with 
AMD. The association between IL-8 and the disease was 
confirmed in our cohort, although it has never been tested 
in other populations. 
According to multivariate logistic regression 
analysis, the identified genetic factors were estimated to 
account for 23% of AMD susceptibility in Italian cohort. 
It is important to note that this estimate accounted for 
all of the associated genes except for RAD51B. Thus, 
RAD51B can be considered a very low risk factor for 
AMD, and it actually loses its significance when taken 
together with more strongly associated genes (CFH, 
ARMS2, IL-8, TIMP3, SLC16A8, VEGFA and COL8A1). 
Moreover, the multivariate logistic regression analysis 
reported that CFH and ARMS2 accounted for 20% 
of the overall genetic susceptibility to AMD, while 
the remaining 3% was attributable to IL-8, TIMP3, 
SLC16A8, VEGFA and COL8A1. Next, we evaluated the 
distribution of the number of risk alleles between cases 
and controls. As expected, the frequency distribution 
in the two groups showed different trends (Figure 2A), 
with a higher number of risk alleles in cases (Figure 2B) 
with respect to control subjects (Figure 2C). In fact, 
considering 7 as the median point out of 14 possible 
variant combinations, we observed a higher number 
of cases with at least 7 risk alleles compared with the 
control group. Thus, the presence of an increased number 
of risk alleles in AMD patients allowed us to presume a 
cumulative effect of genetic variants in determining the 
disease phenotype.
The secondary goal of the study was to estimate the 
contribution of non-genetic factors to the risk of AMD. To 
this end, we decided to consider environmental variables 
(age, sex, smoking and dietary habits) that are known 
to strongly impact the onset/progression of disease. As 
expected, advanced age and smoking status were found to 
be strongly associated risk factors for AMD, while regular 
consumption of fruits and vegetables represented a helpful 
source for preventing disease onset/progression. However, 
our multivariate analysis showed that non-genetic factors 
accounted for 10% of disease, in contrast with the 19–37% 
described in the literature [1]. 
Figure 1: Predicted interactions among the AMD-associated genes. The figure shows the main gene interactions derived by the 
prediction analysis with the bioinformatic tools.
Table 2: Multivariate analysis performed on the non-genetic variables
NON-GENETIC VARIABLES p OR (CI 95%) EFFECT
Age 1.58*10–36 1.4 (1.3–1.5) risk
Smoking habit 1.31*10–4 1.4 (1.2–1.7) risk
Dietary habits (fruits&vegetables) 1.43*10–4 0.6 (0.5–0.8) protective
Sex ns - -
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Afterwards, genetic and non-genetic factors were 
combined in one multivariate analysis, in order to provide 
a comprehensive overview of AMD in Italian population. 
Our results suggested that all tested variants were able 
to cover 29% of disease. In particular, genes (CFH, 
ARMS2, IL-8, TIMP3, SLC16A8, VEGFA and COL8A1), 
old age and smoking status contribute to susceptibility, 
while female sex and regular consumption of fruits and 
vegetables protect from AMD development. 
Interestingly, our results highlighted a prominent 
difference between the Italian and global population, in 
which the genetic contribution has been estimated to range 
from 46% to 71% [1]. These data suggest that Italian-
associated genes may have a greater impact on disease 
in our population. In fact, these genes are sufficient to 
account for 23% of susceptibility, in contrast to the 34 loci 
required to account for 46–71% of AMD risk across the 
global populations. Overall, our results suggest that AMD 
onset in the Italian population may be regulated by distinct 
interaction patterns involving few genes. To this end, we 
explored potential interactions of the associated genes and 
their function. In particular, CFH functions as an essential 
Table 3: Multivariate analysis performed on genetic and non-genetic variables
CONSIDERED VARIABLES p OR (CI 95%) EFFECT
CFH (rs1061170, T/C) 1.29*10–23 C = 2.7 (2.2–3.3) risk
ARMS2 (rs10490924, G/T) 2.19*10–26 T = 3.1(2.5–3.9) risk
IL8 (rs2227306, C/T) 2*10–4 T = 1.4 (1.1–1.7) risk
TIMP3 (rs5749482, C/G) 4*10–4 C = 1.7 (1.5–2.2) risk
VEGFA (rs943080, C/T) 0.032 T = 1.2 (1.0–1.5) risk
RAD51B (rs8017304, A/G) ns - -
SLC16A8 (rs8135665, C/T) 5.71*10–11 T = 2.1 (1.7–2.7) risk
COL8A1 (rs13081855, G/T) 0.014 T = 1.5 (1.1–2.1) risk
Age 2.48*10–19 1.4 (1.3–1.5) risk
Smoking habit 7.85*10–5 1.7 (1.3–2.2) risk
Dietary habits (fruits&vegetables) 0.015 0.6 (0.4–0.9) protective
Female sex 0.04 0.7 (0.5–0.9) protective
Figure 2: Distribution of the number of risk alleles between cases and controls. (A) allele frequency distribution in the two 
groups. (B) allele frequency distribution in cases. (C) allele frequency distribution in control subjects.
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inhibitor of complement activation, and the homozygous 
genotype for the rs1061170 risk allele has been shown to 
increase the activation of the complement cascade [4–5, 
21–22]. Although the role of ARMS2 needs to be clarified, 
studies performed on animal models have reported that 
it may be involved in angiogenesis, extracellular matrix 
mineralization, and transforming growth factor-beta 
signaling [4, 23–24].
In addition, ARMS2 may interact with pro-
inflammatory molecules, such as IL-6, IL-8, TNF-α, C3 
and C5 [23]. IL-8 is known to be a primary mediator 
of angiogenesis, and it is fundamentally involved 
in the chemotaxis of immune cells (neutrophils and 
lymphocytes) to the site of inflammation [20]. Regarding 
the activation of angiogenesis, VEGFA is recognized 
as one of the most important growth factors triggering 
this mechanism [1, 5]. Therefore, it is not surprising 
that our bioinformatic analysis suggested significant 
possible interactions between IL-8, VEGFA, CFH and 
ARMS2. Thus, the involvement of CFH, ARMS2, IL-8 
and VEGFA in the inflammatory, angiogenic and tissue 
homoeostasis pathways fits perfectly with the clinical 
phenotype displayed by patients affected with exudative 
AMD. In addition, the gene/phenotype interaction analysis 
revealed that the risk allele (T) of VEGFA (rs943080) is 
more frequent among patients with type 1 CNV compared 
with those with the type 2 CNV subtype. Importantly, 
rs943080 maps to a highly evolutionary conserved 
region of chromosome 6. In particular, the alternative 
allele C is believed to disrupt the binding site of cone-
rod homeobox (CRX), which is an essential transcription 
factor that is highly expressed in RPE and retinal ganglion 
cells [25–26]. Thus, the disruption of the CRX binding 
site may reduce the expression of VEGFA beneath the 
RPE monolayer and decrease neovascularization in type 
1 exudative AMD. In study involving 223 patients with 
neovascular AMD, subjects carrying the VEGFA rs943080 
risk genotype (TT) had 1.8-fold higher expression of 
VEGFA compared with patients with the protective VEGFA 
rs943080 genotype (CC) variant (p = 0.012) [26]. Based 
on these data, VEGFA genotyping may help clinicians 
to recognize some clinical features indicative of type 1 
exudative AMD. Moreover, the TT genotype of VEGFA 
rs943080 has been associated with a poorer response to 
anti-VEGFA therapy compared with the low-risk genotype 
(CC) [26–27]. These data indicate VEGFA may be a 
pharmacogenetic biomarker that influences the degree of 
response to anti-VEGFA treatments; the biomarker may 
be useful to determine the dosage and administration 
frequency according to the patient’s genotype.
Interestingly, the bioinformatic analysis showed 
a significant interaction between VEGFA and COL8A1. 
The homonymous protein encoded by COL8A1 is a 
major component of Descemet’s membrane of corneal 
and blood vessel endothelial cells. COL8A1 permits the 
migration and proliferation of vascular smooth muscle 
cells, is involved in the maintenance of vessel wall 
integrity and structure and participates in extracellular 
matrix (ECM) remodeling and angiogenesis [4–5, 17]. 
We therefore believe that genetic variants in COL8A1 
may result in altered protein, causing more fragile vessels, 
vessel disruption and the onset of edema that is normally 
associated with wet AMD. Another possible role of 
COL8A1 in AMD pathogenesis may lie in its participation 
in ECM remodeling pathways, which thereby trigger the 
progression of angiogenesis.
Moreover, the TF target bioinformatic analysis 
revealed a significant relationship between COL8A1 
and VEGFA with NFAT transcription factors. The NFAT 
TFs are a family of proteins mainly involved in immune 
responses and VEGF-induced angiogenesis and therefore 
have a potential role in the aetiopathogenesis of AMD 
[28].
Regarding interactions among TIMP3, VEGFA, 
RAD51B and SLC16A8, bioinformatic data indicated 
significant interactions only for RAD51B, VEGFA 
and SLC16A8. In particular, TIMP3 is an inhibitor of 
metalloproteinase 3, which is involved in the degradation 
of extracellular matrix. It is present in BrM, where it 
is essential for ECM maintenance and remodeling [4, 
6, 17]. In this context, AMD-associated variations in 
ECM proteins can alter the structure and permeability 
of the BrM, making it more susceptible to aging and 
environmental abuse. RAD51B is essential for the 
activation of DNA-repair mechanisms and may play a 
role in the induction of RPE and the photoreceptor cell 
death at the root of AMD pathogenesis [5]. SLC16A8 
encodes a transporter protein comprising many short-
chain monocarboxylates that spans the membrane. This 
protein is specifically expressed by the RPE and a deficit 
in lactate transport may cause the retinal acidification 
and photoreceptor dysfunction [17]. Altogether, our 
bioinformatic results provided interesting insights into 
the interactions among AMD-associated genes, which 
may thereby trigger alterations of BrM structure and 
permeability, the induction of angiogenesis and the 
damage caused by aging and environmental factors. 
Clearly, further molecular and cellular experiments are 
necessary to verify the effective relationships between 
CFH, ARMS2, IL-8, TIMP3, SLC16A8, VEGFA and 
COL8A1 in the development and progression of the 
disease. 
Our work provides a general overview of the genetic 
and non-genetic factors (which contribute to the onset 
of exudative AMD in Italian population. The extensive 
analysis performed on 1976 subjects highlighted 8 
genetic variants and 4 non-genetic factors associated with 
exudative AMD. 
Regarding genetic susceptibility, our findings 
differed from global studies that have described many 
more associated variants than the 8 reported above. In 
addition, the bioinformatic analysis revealed interesting 
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insights into the biological functions and interactions 
among the genes associated with AMD in our cohort. 
Our findings suggest that CFH, ARMS2, IL-8, TIMP3, 
SLC16A8, RAD51B, VEGFA and COL8A1 may contribute 
to the onset of wet AMD at different levels, particularly 
the following: induction of angiogenesis; alteration of 
ECM remodeling mechanisms and of BrM integrity and 
permeability; modification of RPE and photoreceptor 
cell activities; and over-activation of inflammatory and 
immune responses.
Regarding environmental effects on the disease, 
our data confirmed previously reported findings. As 
expected, smoking status and advanced age were 
two of the major risk factors for AMD, while regular 
consumption of fruits and vegetables was as preventative 
factor. On the other hand, the association between sex and 
AMD was discordant with previous data. In our study, 
women had a lower risk of disease, while other studies 
have reported non-significant or conflicting data on this 
subject. However, the association value was very weak in 
our study, and may not be relevant in comparison with 
other environmental factors. Overall, our study showed 
that AMD susceptibility within the Italian population is 
contributed to by genetic variants, accounting for 23% 
of disease and non-genetic variants, accounting for 
10% of AMD (Figure 3). The remaining 67% of disease 
susceptibility is still a matter of investigation. Other 
promising biomarkers certainly contribute to disease, 
among which epigenetic factors are of great interest. In this 
context, special attention should be paid to methylation 
patterns and miRNAs, since they are likely to be involved 
in the mechanisms underlying the onset and progression 
of disease. In particular, methylation seems to impact the 
proinflammatory activity and oxidative response which 
are significantly increased in AMD pathogenesis [1, 29]. 
MiRNAs have been closely connected with angiogenic, 
inflammatory and cell survival mechanisms which are 
usually disrupted in case of disease [5, 29]. Although the 
relationship with AMD needs to be clarified, epigenetic 
modifications represent the most promising biomarkers for 
the prediction of the risk/ protection to exudative AMD as 
well as for the development of new drugs.
MATERIALS AND METHODS
Study cohort and DNA extraction
This study enrolled 1976 individuals, including 
976 wet-AMD cases and 1000 control subjects. Cases 
were recruited from the Ophthalmology Unit of the PTV 
General Hospital of Rome, U.O. Oculist Foundation 
IRCCS “Cà Granda” Maggiore General Hospital of 
Milan, Department of Clinical Physiopathology of the 
University of Turin, Department of Clinical Science of 
Sacco Hospital, of Milan. Patients were selected following 
specific inclusion criteria: male or female subjects over the 
age of 50 years, diagnosis of exudative AMD, clear media 
in order to guarantee good quality images. The exclusion 
criteria included: signs of any other macular condition 
predisposing to CNV, any previous intraocular treatment, 
including laser photocoagulation and photodynamic 
therapy with verteporfin (PDT), cataract surgery, allergy 
to fluorescein. The control subjects were recruited from 
the UOSD SIMT and the Ophthalmology Unit of the 
PTV General Hospital of Rome. Recruited subjects were 
asked to reply to a questionnaire in order to classify their 
smoking and dietary habits. Subjects who have never 
smoked or quit smoking ≥ 5 years before recruitment were 
Figure 3: The AMD susceptibility within the Italian population. The chart illustrates the main components able to describe the 
genetic and non-genetic variables contributing to the disease susceptibility in our population.
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classified as non-smokers, otherwise they were considered 
as smokers. Dietary habits were sorted into regular intake 
of fruit and vegetables (≥ 3 times per week) and unusual 
assumption (≤ 2 times per week). All of the data related to 
the characterization of the study cohort are summarized 
in Table 4.
The study was approved by the ethics committee of 
the University of Rome “Tor Vergata” and was performed 
according to the Declaration of Helsinki. All participants 
provided signed informed consent. Blood samples were 
obtained from all subjects in order to extract genomic 
DNA. Genomic DNA extraction was performed using the 
EZ1 Advanced XL automated extractor and the EZ1 DNA 
Blood 200 µl Kit (Qiagen). 
Genotyping analysis
All of the samples (1976 individuals) were 
genotyped for the 22 selected SNPs, which were as 
follows: CFH (rs1061170, T/C), ARMS2 (rs10490924, 
G/T), IL-8 (rs2227306, C/T), C2 (rs547154, C/A; 
rs9332739, G/C), CFB (rs4151667, T/A), C3 (rs2230199, 
C/G), CFI (rs4698775, G/T), TNFRSF10A (rs13278062, 
G/T), TIMP3 (rs5749482, C/G), VEGFA (rs943080, C/T), 
COL8A1 (rs13081855, G/T), SLC16A8 (rs8135665, G/T), 
RAD51B (rs8017304, A/G), ADAM (rs679573, C/T), LIPC 
(rs920915, C/G), APOE (rs4420638, A/G), COL10A1 
(rs3812111, A/T), IER3-DDR1 (rs1864163, A/G), 
B3GALTL (rs9542236, C/T), TGFBR1 (rs334353, T/G), 
and CETP (rs1864163, G/A). The CFI and TNFRSF10A 
genotype analyses were limited by technical issues, and 
therefore the required molecular experiments were not 
successfully completed. 
All samples were genotyped using the TaqMan 
assay on a 7500 Fast Real Time PCR device according 
to the manufacturer’s instructions (Applied Biosystems). 
The genotyping results were interpreted using Sequence 
Detection System 2.1 software (Applied Biosystems). 
Each Real Time PCR run was performed using a negative 
control and three positive control samples previously 
confirmed by direct sequencing (BigDye Terminator 
v3.1, BigDyeXTerminator) on ABI3130xl (Applied 
Biosystems). 
Biostatistical and bioinformatic analysis
The genotyping results were subjected to 
biostatistical analysis to evaluate associations with 
AMD. First, the genotyping data reported in our cohort 
were tested to confirm the Hardy-Weinberg equilibrium 
(p > 0.05). Afterwards, the association of the genotyped 
SNPs were measured by calculating the p-value (p) 
through 2x2 contingency tables (http://www.physics.
csbsju.edu/stats/contingency_NROW_NCOLUMN_
form.html). The statistical associations were considered 
significant when p < 0.05 based on the 95% confidence 
interval. The strength of the associations was determined 
by calculating the Odd Ratio (OR, http://www.hutchon.
net/ConfidOR.htm).
The overall contribution of each genetic and non-
genetic factor to AMD susceptibility was evaluated 
through a multivariate logistic regression analysis 
(stepwise method). The presence/absence of AMD was 
considered the dependent variable. First, the contributions 
of genetic factors associated with AMD in our cohort 
were determined. To this end, the analysis included CFH, 
ARMS2, IL-8, TIMP3, COL8A1, SLC16A8, VEGFA, 
and RAD51B as independent variables. Second, the 
contribution of non-genetic factors was estimated, taking 
into account age, sex, smoking and dietary habits as 
independent variables. The last analysis was performed 
considering both genetic and non-genetic factors as 
independent variables. At each level of the multivariate 
logistic regression analysis, the R2 (logistic regression 
coefficient) indicated the contribution of the considered 
variables to AMD susceptibility. The cut-off for statistical 
Table 4: Collection of data concerning the subjects enrolled in the study
DATA CASES CONTROLS
Age ± 77 years old ±72 years old
Sex F: 54%M: 46%
F: 56%
M: 44%
Type of CNV Type 1:53%Type 2: 47% -
Dietary habits R: 86%S: 14%
R: 79%
S: 21%
Smoking habit Y: 47%N: 53%
Y: 47%
N: 53%
Concerning smoking habits, non-smokers status was assigned to those subjects who never smoked or quit smoking ≥ 5 years 
before recruitment, otherwise they were considered as smokers. Dietary habits were sorted according to the frequency of 
fruits and vegetables intake (≥ 3 times/week for regular consumption and ≤ 2 times/week for unusual consumption). Legend: 
F= female; M: male; R: regular; S: seldom; Y: yes; N: not.
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significance was set at a p < 0.05. The multivariate 
analysis was performed using the SPSS program, ver. 19 
(IBM Corp, Armonk, NY, USA).
Bioinformatic evaluation of genes interactions
All the associated genes were subjected to a 
bioinformatic analysis aimed to evaluate the potential 
presence of specific interactions among them. To this 
end, the WEB-based GEne SeT AnaLysis Toolkit [30] and 
DAVID Bioinformatic Database version 6.8 Beta [31–32] 
were utilized. The software incorporates information from 
different public resources and provides information about 
the possible biological and molecular pathways involving 
the genes of interest. The analysis was performed 
according to the following enrichment tools: GO Analysis, 
Pathway Commons Analysis and Transcription Factor 
Target Analysis. The results were considered significant 
with a cut-off of p < 0.05. 
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